Document Detail

Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor.
MedLine Citation:
PMID:  10397691     Owner:  NLM     Status:  MEDLINE    
Glucocorticoid, an anti-inflammatory agent, inhibits the development of atherosclerosis in various experimental animal models. This is partially explained by its ability to inhibit smooth muscle cell migration and proliferation in the intima and to reduce chemotaxis of circulating monocytes and leukocytes into the subendothelial spaces. We have recently demonstrated that oxidized LDL (Ox-LDL) has a mitogenic activity for macrophages in vitro in which Ox-LDL-induced granulocyte/macrophage colony-stimulating factor (GM-CSF) production plays an important role. Proliferation of cellular components is one of the characteristic events in the development and progression of atherosclerotic lesions. In the present study, we investigated the effects of glucocorticoids on Ox-LDL-induced macrophage growth. Dexamethasone, prednisolone, and cortisol inhibited Ox-LDL-induced thymidine incorporation into macrophages by 85%, 70%, and 50%, respectively. Ox-LDL induced a significant production of GM-CSF by macrophages, which was effectively inhibited by dexamethasone, prednisolone, and cortisol by 80%, 65%, and 50%, respectively. Dexamethasone-mediated inhibition of Ox-LDL-induced GM-CSF mRNA expression and macrophage growth was significantly abrogated by RU-486, a glucocorticoid receptor antagonist. Our results suggest that the inhibitory effects of glucocorticoids on macrophage growth may be due to the inhibition of Ox-LDL-induced GM-CSF production through transactivation of the glucocorticoid receptor.
M Sakai; T Biwa; T Matsumura; T Takemura; H Matsuda; Y Anami; T Sasahara; S Kobori; M Shichiri
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  19     ISSN:  1079-5642     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-07-29     Completed Date:  1999-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1726-33     Citation Subset:  IM    
Department of Metabolic Medicine, Kumamoto University School of Medicine, Division of Cardiology, Kumamoto National Hospital, Kumamoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Division / drug effects
Dexamethasone / pharmacology*
Granulocyte-Macrophage Colony-Stimulating Factor / antagonists & inhibitors*,  biosynthesis,  genetics
Lipoproteins, LDL / antagonists & inhibitors*,  metabolism
Lysophosphatidylcholines / metabolism
Macrophages / drug effects*,  physiology
Mice, Inbred C3H
Mifepristone / pharmacology
RNA, Messenger / analysis
Reg. No./Substance:
0/Lipoproteins, LDL; 0/Lysophosphatidylcholines; 0/RNA, Messenger; 0/oxidized low density lipoprotein; 50-02-2/Dexamethasone; 83869-56-1/Granulocyte-Macrophage Colony-Stimulating Factor; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macropha...
Next Document:  Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in...